Synjardy
These highlights do not include all the information needed to use SYNJARDY and SYNJARDY XR safely and effectively. See full prescribing information for SYNJARDY and SYNJARDY XR. SYNJARDY (empagliflozin and metformin hydrochloride tablets), for oral use SYNJARDY XR (empagliflozin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2015
8006ba29-ee3a-f852-a9bb-c8ec9b41cf66
HUMAN PRESCRIPTION DRUG LABEL
Oct 31, 2023
Boehringer Ingelheim Pharmaceuticals, Inc.
DUNS: 603175944
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
empagliflozin, metformin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
empagliflozin, metformin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
empagliflozin, metformin hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
empagliflozin, metformin hydrochloride
Product Details
FDA regulatory identification and product classification information